Navigation Links
Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
Date:4/9/2009

Millennium Bioceutics, announces the release of it's advanced nutritional supplement, Caplex, to cancer patients worldwide. Caplex contains a unique patent pending formulation created by an Oncologist and Clinical Dietitian. Caplex nutrition supplement provides cancer patients a comprehensive source of the most effective anti-tumor nutrients and herbal compounds based on results accumulated from medical research. Impressive changes in the growth rate of prostate cancer has been seen in patients who take Caplex. Caplex provides a well tolerated all-natural treatment option to cancer patients.

Miami, FL (PRWEB) April 9, 2009 -- Millennium Bioceutics, announces the release of it's advanced nutritional supplement, Caplex, to cancer patients worldwide. Caplex contains a unique patent pending formulation created by an Oncologist and a Clinical Dietitian. The supplement to provide cancer patients a comprehensive source of the most effective anti-tumor nutrients and herbal compounds based on results accumulated from medical research.

Caplex contains 9 powerful cancer fighting nutrients including: Purified Capsaicin, Lycopene, Curcumin, Selenium, Vitamin D & E, Zinc and the Omega 3 Fatty Acids, EPA & DHA. Each of these compounds has shown effectiveness in scientific studies as nutrients with powerful antioxidant properties and the ability to slow and or prevent tumor growth. Now researchers are finding that the effectiveness of these nutrients is further enhanced when taken together, demonstrating an important synergistic effect amongst these nutrients. gy" imgurl="http://image.bio-medicine.org/img/Cancer-Fighting-Nutrition-Supplement--Caplex--Offers-Cancer-Patients-A-New-All-Natural-Treatment-Option.gif" timex="4/9/2009 12:37:49 AM" dirsub="(in are further enhanced when taken at th...)" id="11451" index="biology" dir="Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option" dir2="Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatm..." keywords1=",biological,advanced biology technology,biology laboratory technology,biology device technology,latest biology technology" keywords="Cancer,Fighting,Nutrition,Supplement,,Caplex,,Offers,Cancer,Patients,A,New,All-Natural,Treatment,Option" description="in are further enhanced when taken at the same time. "Caplex has ...Caplex offers an all-natural and well-tolerated treatment option for ...Caplex is available in select pharmacies and can now be ordered direc...# # # ...Read the full story at a href http://www.prweb.com/releases/2009/04/..." url=u&"/biology-technology-1/Cancer-Fighting-Nutrition-Supplement--Caplex--Offers-Cancer-Patients-A-New-All-Natural-Treatment-Option-11451-2/" title="Cancer%20Fighting%20Nutrition%20Supplement%2C%20Caplex%2C%20Offers%20Cancer%20Patients%20A%20New%20All-Natural%20Treatment%20Option" %> Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatm... ( Millennium B...)

Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
Date:4/9/2009

Caplex has a unique combination of nutrients that work together synergistically, providing a powerful cancer fighting formula. This gives patients an easier way to get the benefits of all these nutrients in one readily accessible source.

"We have seen impressive changes in the growth rate of prostate cancer in patients who take Caplex and none of the patients taking it have noted significant side effects," says Nancy Matsuura, Clinical Dietitian and Founder of Millennium Bioceutics.

Caplex offers an all-natural and well-tolerated treatment option for cancer patients and prevention regimens. As with all medications and nutritional supplements, patients should talk to their doctors prior to starting any new treatment options.

Caplex is now available online online at http://www.caplexsupplement.com and coming to leading hospitals and research centers throughout the US. Part of the proceeds go towards cancer research.

# # #

Read the full story at http://www.prweb.com/releases/2009/04/prweb2299274.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program
2. Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations
3. Groundbreaking Research Begins for Pancreatic and Lung Cancers
4. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
5. Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
6. TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
7. Nereus Pharmaceuticals Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer
8. Medarex to Present at the Needham Cancer Therapeutics Conference
9. Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer
10. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
11. Samtheo Announces License Agreement with Moffitt Cancer Center for Exclusive Rights to Novel Akt Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ... of online age and identity verification solutions, announced today ... Identity Conference 2017, May 15 thru May 17, 2017, ... Building and International Trade Center. Identity ... globe and in today,s quickly evolving digital world, defining ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
Breaking Biology News(10 mins):